Aqueous inhalation pharmaceutical composition

Details Aqueous inhalation pharmaceutical composition Aqueous inhalation pharmaceutical composition

2006-05-25

2011-11-15

Noakes, Suzanne M (Department: 1656)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

08058236

ABSTRACT:
An aqueous inhalation pharmaceutical composition comprising a polypeptide or protein is provided. The composition of the present invention can improve the bioavailability of the polypeptide and protein, and avoid inducing toxicity in the lung.

REFERENCES:
patent: 5997848 (1999-12-01), Patton et al.
patent: 6375975 (2002-04-01), Modi
patent: 6702997 (2004-03-01), Chaudry et al.
patent: 2003/0198602 (2003-10-01), Chen et al.
patent: 0845265 (1998-06-01), None
patent: 06507904 (1994-09-01), None
patent: 08512027 (1996-12-01), None
patent: 10510827 (1998-10-01), None
patent: 11292787 (1999-10-01), None
patent: 2003-519175 (2003-06-01), None
patent: 2004-532861 (2004-10-01), None
patent: 9221017 (1992-11-01), None
patent: 9500127 (1995-01-01), None
patent: 9619197 (1996-06-01), None
patent: 0149274 (2001-07-01), None
patent: 02094342 (2002-11-01), None
Ngo et al., in the Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
Hagerman et al., Expert Opinion on Drug Delivery, Jan. 2006, vol. 3, No. 1, pp. 71-86.
Mollmann et al. (Pharmaceutical Research, vol. 22, No. 11, Nov. 2005).
Weber et al. (Pediatric Pulmonology 23: 249-260, 1997).
Sodium dodecyl sulfate, [online], retrived from <URL: http://en.wikipedia.org/wiki/Sodium—lauryl—sulfate>, retrieved the Internet on May 22, 2007.
Shao et al., “Bile Salt-Fatty Acid Mixed Micelles as Nasal Absorption Promotors. III. Effects on Nasal Transport and Enzymatic Degradation of Acyclovir Prodrugs”, Pharmaceutical Research, vol. 11, No. 2, pp. 243-250, 1994 Plenum Publishing Corporation.
Patton et al., “Clinical Pharmacokinetics and Pharmacodynamics of Inhaled Insulin”, Clinical Pharmacokinetic, vol. 43, No. 12, pp. 781-801, 2004 Adis Data Information BV.
Pontiroli et al., “Intranasal Drug Delivery Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective”, Clinical Pharrnacokinet, vol. 17, No. 5, pp. 299-307 1989.

Affiliated with

Also associated with

Rating

Aqueous inhalation pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aqueous inhalation pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous inhalation pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4266326